Simvastatin Inhibits Activation of NADPH Oxidase/p38 MAPK Pathway and Enhances Expression of Antioxidant Protein in Parkinson Disease Models.
about
Simvastatin Inhibits Activation of NADPH Oxidase/p38 MAPK Pathway and Enhances Expression of Antioxidant Protein in Parkinson Disease Models.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Simvastatin Inhibits Activatio ...... n in Parkinson Disease Models.
@en
Simvastatin Inhibits Activatio ...... n in Parkinson Disease Models.
@nl
type
label
Simvastatin Inhibits Activatio ...... n in Parkinson Disease Models.
@en
Simvastatin Inhibits Activatio ...... n in Parkinson Disease Models.
@nl
prefLabel
Simvastatin Inhibits Activatio ...... n in Parkinson Disease Models.
@en
Simvastatin Inhibits Activatio ...... n in Parkinson Disease Models.
@nl
P2093
P2860
P356
P1476
Simvastatin Inhibits Activatio ...... n in Parkinson Disease Models.
@en
P2093
Dongmei Mai
Huichun Tong
Shaogang Qu
Xingjun Meng
Xiuping Zhang
P2860
P356
10.3389/FNMOL.2018.00165
P577
2018-05-22T00:00:00Z